Journal of Antimicrobial Chemotherapy, 0305-7453

Journal

161 - 172 out of 172Page size: 20
Sort by: Title

Publications

  1. Published

    Accumulation of rifampicin by Mycobacterium aurum, Mycobacterium smegmatis and Mycobacterium tuberculosis

    Laura Piddock & Vito Ricci, Feb 2000, In: Journal of Antimicrobial Chemotherapy. 45, 2, p. 159-65 7 p.

    Research output: Contribution to journal › Article › peer-review

  2. Published

    Accumulation of rifampicin by Escherichia coli and Staphylococcus aureus

    Laura Piddock, Nov 1998, In: Journal of Antimicrobial Chemotherapy. 42, 5, p. 597-603 7 p.

    Research output: Contribution to journal › Article › peer-review

  3. Published

    Accumulation of garenoxacin by Bacteroides fragilis compared with that of five fluoroquinolones

    Vito Ricci & Laura Piddock, Oct 2003, In: Journal of Antimicrobial Chemotherapy. 52, 4, p. 605-9 5 p.

    Research output: Contribution to journal › Article › peer-review

  4. Published

    Accumulation of five fluoroquinolones by Mycobacterium tuberculosis H37R

    Laura Piddock & Vito Ricci, 1 Dec 2001, In: Journal of Antimicrobial Chemotherapy. 48, 6, p. 787-91 5 p.

    Research output: Contribution to journal › Article

  5. Published

    Accumulation of KRM-1648 by Mycobacterium aurum and Mycobacterium tuberculosis

    Laura Piddock & Vito Ricci, May 2000, In: Journal of Antimicrobial Chemotherapy. 45, 5, p. 681-4 4 p.

    Research output: Contribution to journal › Article › peer-review

  6. Published

    Accumulation and killing kinetics of fifteen quinolones for Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa

    Laura Piddock, Jun 1993, In: Journal of Antimicrobial Chemotherapy. 31, 6, p. 865-80 16 p.

    Research output: Contribution to journal › Article › peer-review

  7. Published

    A population-dynamic model for evaluating the potential spread of drug-resistant influenza virus infections during community-based use of antivirals

    Sue Mallett, Apr 2003, In: Journal of Antimicrobial Chemotherapy. 51, 4, p. 977-90 14 p.

    Research output: Contribution to journal › Article › peer-review

  8. Published

    A novel reverse-line hybridization assay for identifying genotypes of CTX-M-type extended-spectrum  -lactamases

    Peter Hawkey, 25 Jan 2007, In: Journal of Antimicrobial Chemotherapy. 59, 3, p. 387-95 9 p.

    Research output: Contribution to journal › Article

  9. Published

    A comparison of the mechanisms of decreased susceptibility of aztreonam-resistant and ceftazidime-resistant Enterobacteriaceae

    Laura Piddock, Dec 1990, In: Journal of Antimicrobial Chemotherapy. 26, 6, p. 749-62 14 p.

    Research output: Contribution to journal › Article › peer-review

  10. Published

    A comparison of methods used for measuring the accumulation of quinolones by Enterobacteriaceae, Pseudomonas aeruginosa and Staphylococcus aureus

    Laura Piddock, Nov 1991, In: Journal of Antimicrobial Chemotherapy. 28, 5, p. 639-53 15 p.

    Research output: Contribution to journal › Article › peer-review

  11. Published

    A 96-well plate fluorescence assay for assessment of cellular permeability and active efflux in Salmonella enterica serovar Typhimurium and Escherichia coli

    Mark Webber & Laura Piddock, 1 Aug 2010, In: Journal of Antimicrobial Chemotherapy. 65, 8, p. 1655-1663 9 p.

    Research output: Contribution to journal › Article

  12. E-pub ahead of print

    Candida albicans enhances meropenem tolerance of Pseudomonas aeruginosa in a dual-species biofilm

    Jessica Blair & Rebecca Hall, 22 Dec 2019, In: Journal of Antimicrobial Chemotherapy. p. 1-11 11 p., dkz514.

    Research output: Contribution to journal › Article › peer-review

Previous 1...5 6 7 8 9 Next